No Data
No Data
ReWalk Robotics Second Quarter 2024 Earnings: EPS Beats Expectations
Lake Street Maintains ReWalk Robotics(LFWD.US) With Buy Rating, Maintains Target Price $8.5
Rewalk Robotics Analyst Ratings
H.C. Wainwright Maintains ReWalk Robotics(LFWD.US) With Buy Rating, Maintains Target Price $13
Analysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI)
Express News | Rewalk Robotics Ltd : H.c. Wainwright Raises Target Price to $13 From $9
No Data